Evogene's top three insider shareholders as of September 29, 2026 are Leon Recanati (Director, 1.34Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Leon Recanati | Director | 1,343,886 | 0 | 1,343,886 | 100.0% | 13 Aug, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Sep, 2026 | Nir Nimrodi | Director | Acquired A | 10,000 | $0.00 | $0 | 10,000 | Direct |
| 04 Sep, 2026 | Dan Michael Falk | Director | Acquired A | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 04 Sep, 2026 | Adrian John Percy | Director | Acquired A | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 04 Sep, 2026 | Leon Recanati | Director | Acquired A | 2,500 | $0.00 | $0 | 2,500 | Direct |
| 11 Aug, 2026 | Leon Recanati | Director | Acquired P | 460,000 | $0.64 | $292.10K | 1,343,886 | Direct |
| 04 Aug, 2026 | Leon Recanati | Director | Acquired P | 800,000 | $0.50 | $400.00K | 883,886 | Direct |